Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 3
2015 1
2016 1
2017 2
2019 4
2020 1
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy in Mast Cell Leukemia.
Laforgia M, Calabrò C, Scattone A, Laface C, Porcelli M, Gadaleta CD, Nardulli P, Ranieri G. Laforgia M, et al. Among authors: nardulli p. Expert Opin Pharmacother. 2020 Jun;21(9):1059-1069. doi: 10.1080/14656566.2020.1744566. Epub 2020 Mar 25. Expert Opin Pharmacother. 2020. PMID: 32208985 Review.
Immunotherapeutic approaches for hepatocellular carcinoma.
Longo V, Gnoni A, Casadei Gardini A, Pisconti S, Licchetta A, Scartozzi M, Memeo R, Palmieri VO, Aprile G, Santini D, Nardulli P, Silvestris N, Brunetti O. Longo V, et al. Among authors: nardulli p. Oncotarget. 2017 May 16;8(20):33897-33910. doi: 10.18632/oncotarget.15406. Oncotarget. 2017. PMID: 28420805 Free PMC article. Review.
An evaluation of masitinib for treating systemic mastocytosis.
Laforgia M, Marech I, Nardulli P, Calabrò C, Gadaleta CD, Ranieri G. Laforgia M, et al. Among authors: nardulli p. Expert Opin Pharmacother. 2019 Sep;20(13):1539-1550. doi: 10.1080/14656566.2019.1645121. Epub 2019 Aug 5. Expert Opin Pharmacother. 2019. PMID: 31381378 Review.
An updated patent review on P-glycoprotein inhibitors (2011-2018).
Leopoldo M, Nardulli P, Contino M, Leonetti F, Luurtsema G, Colabufo NA. Leopoldo M, et al. Among authors: nardulli p. Expert Opin Ther Pat. 2019 Jun;29(6):455-461. doi: 10.1080/13543776.2019.1618273. Epub 2019 May 17. Expert Opin Ther Pat. 2019. PMID: 31079547 Review.
Target therapies in pancreatic carcinoma.
Silvestris N, Gnoni A, Brunetti AE, Vincenti L, Santini D, Tonini G, Merchionne F, Maiello E, Lorusso V, Nardulli P, Azzariti A, Reni M. Silvestris N, et al. Among authors: nardulli p. Curr Med Chem. 2014;21(8):948-65. doi: 10.2174/09298673113209990238. Curr Med Chem. 2014. PMID: 23992319 Review.
Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.
Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S, Silvestris N. Gnoni A, et al. Among authors: nardulli p. Int J Mol Sci. 2013 Sep 30;14(10):19731-62. doi: 10.3390/ijms141019731. Int J Mol Sci. 2013. PMID: 24084722 Free PMC article. Review.
20 results